Drance
SM. Glaucoma: a look beyond intraocular pressure. Am J Ophthalmol. 1997;123817- 819
Quigley
HA. The search for glaucoma genes: implications for pathogenesis and disease detection. N Engl J Med. 1998;3381063- 1064
Broadway
DC, Nicolela
MT, Drance
SM. Optic disk appearances in primary open-angle glaucoma. Surv Ophthalmol. 1999;43
((suppl 1))
S223- S243
Hayreh
SS. The role of age and cardiovascular disease in glaucomatous optic neuropathy. Surv Ophthalmol. 1999;43
((suppl 1))
S27- S42
Change
HS, Harris
A, Evans
DW, Kagemann
L, Garzozi
HJ, Martin
B. Vascular aspects in the pathophysiology of glaucomatous optic neuropathy. Surv Ophthalmol. 1999;43
((suppl 1))
S43- S50
Wall
M, Kutzko
KE, Chauhan
BC. Variability in patients with glaucomatous visual field damage is reduced using size V stimuli. Invest Ophthalmol Vis Sci. 1997;38426- 435
Arend
O, Harris
A, Arend
S, Remky
A, Martin
BJ. The acute effect of topical beta-adrenoreceptor blocking agents on retinal and optic nerve head circulation. Acta Ophthalmol Scand. 1998;7643- 49
Hayreh
SS, Podhajsky
P, Zimmerman
MB. Beta-blocker eyedrops and nocturnal arterial hypotension. Am J Ophthalmol. 1999;128301- 319
Gottfredsdottir
MS, Allingham
RR, Shields
MB. Physicians' guide to interactions between glaucoma and systemic medications. J Glaucoma. 1997;6377- 383
Schulzer
M, Drance
SM, Carter
CJ, Brooks
DE, Douglas
GR, Lau
W. Biostatistical evidence for two distinct chronic open angle glaucoma populations. Br J Ophthalmol. 1990;74196- 200
Tyler
CW, Ryu
S, Stamper
R. The relation between visual sensitivity and intraocular pressure in normal eyes. Invest Ophthalmol Vis Sci. 1984;25103- 105
Eisner
A, Cioffi
GA, Campbell
HMK, Samples
JR. Foveal flicker sensitivity abnormalities in early glaucoma: associations with high blood pressure. J Glaucoma. 1994;3
((suppl))
S19- S31
Eisner
A, Samples
JR, Campbell
HMK, Cioffi
GA. Foveal adaptation abnormalities in early glaucoma. J Opt Soc Am A. 1995;122318- 2328
Guyton
AC. Textbook of Medical Physiology. 6th ed. Philadelphia, Pa WB Saunders Co1981;Part V: The Circulation
Eisner
A, Samples
JR. Profound reductions of flicker sensitivity in the elderly: can glaucoma involve the retina distal to ganglion cells? Appl Optics. 1991;302121- 2135
Eisner
A, Shapiro
AG, Middleton
JA. Equivalence between temporal frequency and modulation depth for flicker response suppression: analysis of a three-process model of visual adaptation. J Opt Soc Am A Opt Image Sci Vis. 1998;151987- 2002
Berne
RM, Levy
MN. Cardiovascular Physiology. 6th ed. St Louis, Mo Mosby–Year Book Inc1992;
Drance
SM, Crichton
A, Mills
RP. Comparison of the effect of latanoprost 0.005% and timolol 0.5% on the calculated ocular perfusion pressure in patients with normal-tension glaucoma. Am J Ophthalmol. 1998;125585- 592
Harris
A, Ciulla
TA, Chung
HS, Martin
B. Regulation of retinal and optic nerve blood flow. Arch Ophthalmol. 1998;1161491- 1495
Lachenmayr
BJ, Drance
SM. The selective effects of elevated intraocular pressure on temporal resolution. Ger J Ophthalmol. 1992;126- 31
Stamper
RL. Psychophysical changes in glaucoma. Surv Ophthalmol. 1989;33
((suppl))
309- 318
Sample
PA, Madrid
ME, Weinreb
RN. Evidence for a variety of functional defects in glaucoma-suspect eyes. J Glaucoma. 1994;3
((suppl))
S5- S18
Klein
R, Klein
BE, Moss
SE. The relation of systemic hypertension to changes in the retinal vasculature: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc. 1997;95329- 348
Klein
BE, Klein
R, Linton
KL. Intraocular pressure in an American community: the Beaver Dam Eye Study. Invest Ophthalmol Vis Sci. 1992;332224- 2228
Curcio
CA, Drucker
DN. Retinal ganglion cells in Alzheimer's disease and aging. Ann Neurol. 1993;33248- 257
Healey
PR, Mitchell
P, Smith
W, Wang
JJ. The influence of age and intraocular pressure on the optic cup in a normal population. J Glaucoma. 1997;6274- 278
Hernandez
MR, Pena
JD. The optic nerve head in glaucomatous optic neuropathy. Arch Ophthalmol. 1997;115389- 395
Hood
DC. Lower-level visual processing and models of light adaptation. Annu Rev Psychol. 1998;49503- 535
Lange
G, Denny
N, Frumkes
TE. Suppressive rod-cone interactions: evidence for separate retinal (temporal) and extraretinal (spatial) mechanisms in achromatic vision. J Opt Soc Am A. 1997;142487- 2498
Seiple
W, Holopigian
K, Greenstein
V, Hood
DC. Temporal frequency dependent adaptation at the level of the outer retina in humans. Vision Res. 1992;322043- 2048
Lee
BB, Pokorny
J, Smith
VC, Martin
PR, Valberg
A. Luminance and chromatic modulation sensitivity of macaque ganglion cells and human observers. J Opt Soc Am A. 1990;72223- 2236
Eisner
A, MacLeod
DIA. Flicker photometric study of chromatic adaptation: selective suppression of cone inputs by colored backgrounds. J Opt Soc Am. 1981;71705- 717
Stockman
A, MacLeod
DIA, Vivien
JA. Isolation of the middle- and long-wavelength- sensitive cones in normal trichromats. J Opt Soc Am A. 1993;102471- 2490
Bill
A, Sperber
GO. Control of retinal and choroidal blood flow. Eye. 1990;4319- 325
Ibrahim
YW, Bots
ML, Mulder
PG, Grobbee
DE, Hofman
A, de Jong
PT. Number of perifoveal vessels in aging, hypertension, and atherosclerosis: the Rotterdam Study. Invest Ophthalmol Vis Sci. 1998;391049- 1053
Hubbard
LD, Brothers
RJ, King
WN.
et al. Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study. Ophthalmology. 1999;1062269- 2280
Formaz
F, Riva
CE, Geiser
M. Diffuse luminance flicker increases retinal vessel diameter in humans. Curr Eye Res. 1997;161252- 1257
Scheiner
AJ, Riva
CE, Kazahaya
K, Petrig
BL. Effect of flicker on macular blood flow assessed by the blue field simulation technique. Invest Ophthalmol Vis Sci. 1994;353436- 3441
Kondo
M, Wang
L, Bill
A. The role of nitric oxide in hyperaemic response to flicker in the retina and optic nerve in cats. Acta Ophthalmol Scand. 1997;75232- 235
Kiryu
J, Asrani
S, Shahidi
M, Mori
M, Zeimer
R. Local response of the primate retinal microcirculation to increased metabolic demand induced by flicker. Invest Ophthalmol Vis Sci. 1995;361240- 1246
Buerk
DG, Riva
CE, Cranstoun
SD. Nitric oxide has a vasodilatory role in cat optic nerve head during flicker stimuli. Microvasc Res. 1996;5213- 26
Brown
SM, Jampol
LM. New concepts of regulation of retinal vessel tone. Arch Ophthalmol. 1996;114199- 204
Kelly
MEM, Barnes
S. Physiology and pathophysiology of nitric oxide in the retina. Neuroscientist. 1997;3357- 360
Osborne
NN, Ugarte
M, Chao
M.
et al. Neuroprotection in relation to retinal ischemia and relevance to glaucoma. Surv Ophthalmol. 1999;43
((suppl 1))
S102- S128
Napper
GA, Pianta
MJ, Kalloniatis
M. Reduced glutamate uptake by retinal glial cells under ischemic/hypoxic conditions. Vis Neurosci. 1999;16149- 158
Cadenas
ID, Reifsnider
ES, Tranchina
D. Modulation of synaptic transfer between retinal cones and horizontal cells by spatial contrast. J Gen Physiol. 1994;104567- 591
Goldstein
IM, Ostwald
P, Roth
S. Nitric oxide: a review of its role in retinal function and disease. Vision Res. 1996;362979- 2994
Kalloniatis
M, Tomisich
G. Amino acid neurochemistry of the vertebrate retina. Prog Retin Eye Res. 1999;18811- 866
Dreyer
EB, Zurakowski
D, Schumer
RA, Podos
SM, Lipton
SA. Elevated glutamate in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol. 1996;114299- 305
Vorwerk
CK, Gorla
MS, Dreyer
EB. An experimental basis for implicating excitotoxicity in glaucomatous optic neuropathy. Surv Ophthalmol. 1999;43
((suppl 1))
S142- S150
Neufeld
AH, Hernandez
MR, Gonzalez
M. Nitric oxide synthase in the human glaucomatous optic nerve head. Arch Ophthalmol. 1997;115497- 503
Neufeld
AH, Sawada
A, Becker
B. Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proc Natl Acad Sci U S A. 1999;969944- 9948
Haynes
WG, Noon
JP, Walker
BR, Webb
DJ. Inhibition of nitric oxide synthesis increases blood pressure in healthy humans. J Hypertens. 1993;111375- 1380